Novo Nordisk Production Belgium SA SA
587.2 FTENovo Nordisk Production Belgium SA reported revenue of €246.3m for the 2025 financial year (annual accounts filed with the NBB on 03 Jul 2026), with 587.2 full-time equivalents.
By total assets for 2025, Novo Nordisk Production Belgium SA ranks among the 20 largest of the 174 companies in its sector (NACE 2120) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Novo Nordisk Production Belgium SA shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +371 % Equity +16 % Total assets +11 % Headcount (avg FTE) +14 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Novo Nordisk Production Belgium SA's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €246.3m | ||||
| Net result | €11.9m | ||||
| Equity | €74.2m | ||||
| Cash | €6.50m | ||||
| EBITDA | €35.5m | ||||
| Total assets | €153.5m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Jul 2026
- Year ended 30 Jun 2024filed on 19 Dec 2024
- Year ended 30 Jun 2023filed on 14 Dec 2023
- Year ended 30 Jun 2022filed on 02 Dec 2022
- Year ended 30 Jun 2021filed on 05 Jan 2022
Novo Nordisk Production Belgium SA's financial analysis
- Solvency48.4%sector median: 41.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Novo Nordisk Production Belgium SA
8 active director(s) in the register.
and 2 more
Novo Nordisk Production Belgium SA's shareholders and holdings →Novo Nordisk Production Belgium SA's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0465.935.738
- VAT number
- BE0465935738
- Peppol
- Registered · 0208:0465935738 · as of 14 Nov 2026
- Legal form
- SA
- Incorporated
- 22 Apr 1999
- Registered office
- 1120 Brussels
- Size
- Large · 587.2 FTE
- Latest accounts
- 2025 · filed on 03 Jul 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Novo Nordisk Production Belgium SA (SA) has been based in Brussels since 1999, active in: manufacture of medicaments. For 2025, it reports revenue of €246.3m, a net profit of €11.9m and equity of €74.2m. With 587.2 full-time equivalents, it is a large enterprise by headcount. Its solvency stands at 48.4%, above the median of its sector (41.4%).
Guide: Checking a Belgian supplier invoice: numbers and IBAN →
Companies similar to Novo Nordisk Production Belgium SA
Companies in the same business, of comparable size and area, outside its group.
- Baxter Manufacture of pharmaceutical preparations Lessines · balance sheet €160.0m
- Odyssea Pharma Manufacture of pharmaceutical preparations Grâce-Hollogne · balance sheet €91.0m
- Ipsen Manufacture of pharmaceutical preparations Brussels · balance sheet €134.4m
- Alcon Laboratories Belgium Manufacture of pharmaceutical preparations Puurs-Sint-Amands · balance sheet €107.2m
- Novartis Manufacturing Manufacture of pharmaceutical preparations Puurs-Sint-Amands · balance sheet €285.2m
- Laboratoires S.M.B. Manufacture of pharmaceutical preparations Molenbeek-Saint-Jean · balance sheet €261.5m
- Roche Manufacture of pharmaceutical preparations Anderlecht · balance sheet €164.7m
- Tilman Manufacture of pharmaceutical preparations Somme-Leuze · balance sheet €43.2m
Frequently asked questions about Novo Nordisk Production Belgium SA
What is the revenue of Novo Nordisk Production Belgium SA?
According to the 2025 annual accounts filed with the NBB, the revenue of Novo Nordisk Production Belgium SA amounts to 246,321,872 €.
What is the VAT number of Novo Nordisk Production Belgium SA?
In Belgium, the VAT number is the company number prefixed with BE: BE0465935738 for Novo Nordisk Production Belgium SA, if the company is VAT-registered. Its company number (CBE) is 0465.935.738.
Where is the registered office of Novo Nordisk Production Belgium SA?
According to the CBE register, the registered office of Novo Nordisk Production Belgium SA is in 1120 Brussels.
What is the equity of Novo Nordisk Production Belgium SA?
At the close of the 2025 financial year, the equity of Novo Nordisk Production Belgium SA amounts to 74,224,921 €, a solvency of 48.4% of total assets.
How many people work at Novo Nordisk Production Belgium SA?
587.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Novo Nordisk Production Belgium SA?
The register lists 8 active mandates at Novo Nordisk Production Belgium SA. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Novo Nordisk Production Belgium SA within its sector?
By total assets for 2025, Novo Nordisk Production Belgium SA ranks among the 20 largest of the 174 companies in its sector (NACE 2120) in Belgium that filed accounts for that financial year.
The full file of Novo Nordisk Production Belgium SA
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →